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Loss of a Tumor Suppressor Gene Causes Polycystic Kidney Disease
Homozygous deficiency of the tuberous sclerosis 2 (Tsc2) gene causes embryonic lethality in rats. Heterozygous animals
for a mutant Tsc2 allele develop renal cell carcinomas in frequencies close to 100%, after inactivation of the normal Tsc2
allele. Loss of the normal allele occurs in preneoplastic lesions and coincides with increased expression of transforming
growth factor , similar to human renal cell carcinomas. Cai et al (Am J Pathol 2003, 162:457–468) report that loss of
heterozygosity (LOH) at the Tsc2 locus during embryonic development caused severe polycystic kidney disease in Eker
rats. In addition, spleen and uterine tumors developed in young animals. Tsc2 interacts with Pkd1, the polycystic kidney
disease 1 gene product. In the affected rats, Pkd1 was intact, demonstrating a direct relationship between Tsc2 and
polycystic renal disease. A commentary by D.M. Hockenberry (Am J Pathol 2003, 162:369–371) discusses this important
finding in more detail.
Profiling of Vascular and Lymphatic Endothelial Cells
There has been enormous progress in understanding the mechanisms of angiogenesis and endothelial cell functions.
Most of this work involves the blood vascular system, but much less information is available on lymphatic vessels. A major
barrier for studies on lymphatic vessels is the difficulty of developing adequate experimental procedures for the required
analyses. Hirakawa et al (Am J Pathol 2003, 162: 575–586) obtained lymphatic endothelial cells (LEC) by immunomag-
netic selection of CD34/CD31 cells directly from human skin. These cells, as well as blood vascular endothelial cells,
were placed in culture and analyzed for their transcriptional profiles. LEC, but not blood vascular cells, expressed the
lymphatic marker Prox1 as well as LYVE-1, a marker that was also expressed in vascular structures produced by
implantation of LEC in vivo. The work identified patterns of gene expression in blood vascular and lymphatic endothelium
and is of great importance for the understanding of vasculogenesis in embryonic development and in adults.
Direct Role of the Alternative Complement Pathway in Intestinal Ischemia/Reperfusion Injury
It has been firmly established that the complement system is involved in ischemia/reperfusion (I/R) injury in various
organs. However, there is no precise information about the role by different pathways of complement activation in I/R
injury. Factor D cleavage of factor B to form the C3bBb convertase is the rate-limiting step for the activation of the
complement alternative pathway. Stahl et al (Am J Pathol 2003, 162: 449–455) used factor D knockout and heterozygous
mice to study the role of the alternative complement pathway in I/R injury in the intestine. Injury after I/R, as measured
by LDH and intestinal myeloperoxidase activity, was much higher in factor D knockout animals than in heterozygous
mice. Addition of factor D to knockout mice restored a normal response to intestinal I/R injury and could be prevented
by factor D antibodies. The data demonstrate that factor D may be an important target for the control of I/R injury. The
role of complement pathways in I/R is discussed in a commentary by Riedemann and Ward (Am J Pathol 2003,
162:363–367).
The Shh (Sonic Hedgehog) Gene May Be Involved in Pulmonary Hypoplasia
The Shh gene is involved in many steps of embryonic development including branching morphogenesis in the lung. Shh
acts by binding to the receptor molecule called “Patched,” which releases the repression of a second membrane
receptor (“Smoothened”) activating at least three lung transcription factors. The mortality of babies with congenital
diaphragmatic hernia (CDH) is primarily attributed to lung hypoplasia, although the mechanisms of this defect, which
causes a 20 to 40% mortality rate, are not known. Unger et al (Am J Pathol 2003, 162:547–555) studied Shh expression
in human and rat developing normal lungs and compared the patterns of expression to those in lungs with pulmonary
hypoplasia secondary to CDH and in an animal model for the disease. Shh expression was highest once the tracheo-
bronchial tree has been formed and was diminished in hypoplastic lungs at early stages of development. It reached a
maximum at much later stages in hypoplastic lungs, at a time in which Shh expression had already declined in normal
lungs. The results suggest that Shh may be important in the pathogenesis of pulmonary hypoplasia associated with CDH,
although more studies are needed to prove a causal relationship.
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TGF Is Required for Healing of the Intestinal Mucosa
TGF has a multitude of biological effects and can mediate cell differentiation, migration, proliferation, fibrogenesis, and
healing. Investigators have attempted to sort out these various mechanisms using TGF1 knockout mice. However, these
animals die rapidly with multi-focal inflammation and thus do not constitute an adequate tool to analyze tissue-specific
abnormalities caused by TGF1 deficiency. Beck et al (Am J Pathol 2003, 162:597–608) produced mice that overex-
press a dominant negative form of TGF receptor type II under the regulation of a modified liver fatty acid binding
promoter. The truncated TGF receptor was expressed in intestinal cells and made these cells unable to respond to
TGF (the truncation produces a molecule that binds the receptor but does not signal). The transgenic mice showed no
changes in epithelial cell proliferation and developed and survived normally. However, they were highly susceptible to
dextran sodium sulfate-induced colitis and had poor recovery from the injury. The results demonstrate that TGF is
required for healing of the intestinal mucosa after injury.
Genomic Instability Is Present in Normal and Abnormal Regions of the Colon of Ulcerative Colitis
Patients with Dysplasia and Cancer
The development of colon cancer in patients with ulcerative colitis (UC) differs from that of sporadic colon cancer
primarily because dysplasia in UC patients is multi-focal. Recent data have identified field effects in areas of normal
appearing mucosa adjacent to tumors suggesting that in UC patients, chromosomal instability may involve large
segments of the colon when cancer and/or dysplasia are present. Chen et al (Am J Pathol 2003, 162:665–672)
developed a PCR method (ISSR-PCR or intersimple sequence repeat) and used it together with arbitrarily primed PCR
to determine the variation in DNA sequences in biopsies from UC patients containing non-dysplastic, dysplastic, and
neoplastic tissues. Patients with dysplasia/cancer had significant levels of genomic instability in both dysplastic and
non-dysplastic colonic mucosa. Instability was detectable only at low frequency in UC patients without dysplasia/cancer.
The work demonstrates that there is generalized genomic instability in the colon mucosa of UC patients who develop
dysplasia or cancer.
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